Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition

NCT01603134 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting State

Interventions

DRUG: Allopurinol
DRUG: Allopurinol

Sponsor

IPCA Laboratories Ltd.